Showing results (821-830 of 7,629) with videos related to
Sort By:
Pageof 763
American Journal of Hematology|August 20, 2019
World Health Organization-defined eosinophilic disorders: 2019 update on diagnosis, risk stratification, and managementWilliam Shomali, Jason GotlibAmerican Journal of Hematology|September 10, 2019
Comparison of non-myeloablative and reduced-intensity allogeneic stem cell transplantation in older patients with myelodysplastic syndromesMadlen Jentzsch, Christine Döhring, Richard Linke, et al.American Journal of Hematology|October 2, 2019
Preventing infectious complications when treating non-malignant immune-mediated hematologic disordersLuis Malpica, David van Duin, Stephan MollAmerican Journal of Hematology|April 1, 1986
Studies on the effects of primary therapy for DIC following circulatory arrestY Takemoto, S Tanaka, J Tanabe, et al.American Journal of Hematology|May 1, 1986
Association of HLA and autoantibody in transfused sickle cell disease patientsM D Ofosu, D A Saunders, G M Dunston, et al.American Journal of Hematology|August 1, 1987
Malignant granular lymphoproliferation after Epstein-Barr virus infection: partial immunologic reconstitution with interleukin-2F R Aronson, R A Dempsey, M Allegretta, et al.American Journal of Hematology|October 30, 2018
Loss of the GPI-anchor in B-lymphoblastic leukemia by epigenetic downregulation of PIGH expressionFloris C Loeff, Kevin Rijs, Esther H M van Egmond, et al.American Journal of Hematology|November 6, 2018
Treatment-free remission with first- and second-generation tyrosine kinase inhibitorsJorge Cortes, Delphine Rea, Jeffrey H LiptonAmerican Journal of Hematology|November 6, 2018
Development of a patient-reported outcomes symptom measure for patients with nontransfusion-dependent thalassemia (NTDT-PRO© )Ali Taher, Vip Viprakasit, Maria Domenica Cappellini, et al.American Journal of Hematology|March 13, 2019
Diffuse large B-cell lymphoma: 2019 update on diagnosis, risk stratification, and treatmentYang Liu, Stefan Klaus BartaPageof 763